BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
-0.6%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
AUM
$1.9B
AUM Growth
+$1.9B
Cap. Flow
+$26.4M
Cap. Flow %
1.39%
Top 10 Hldgs %
54.31%
Holding
63
New
4
Increased
4
Reduced
2
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$7.1B
$166M 8.75% 4,279,464
SWTX
2
DELISTED
SpringWorks Therapeutics
SWTX
$129M 6.79% 3,421,541
CYTK icon
3
Cytokinetics
CYTK
$4.23B
$114M 5.99% 2,100,000
MRUS icon
4
Merus
MRUS
$4.98B
$112M 5.92% 1,900,000
TYRA icon
5
Tyra Biosciences
TYRA
$675M
$103M 5.43% 6,448,359
SRPT icon
6
Sarepta Therapeutics
SRPT
$1.78B
$103M 5.41% 650,000
NUVL icon
7
Nuvalent
NUVL
$5.52B
$85M 4.48% 1,120,192
IDYA icon
8
IDEAYA Biosciences
IDYA
$2.15B
$77.3M 4.07% 2,202,812
ONC
9
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$71.3M 3.76% 500,000
RNA icon
10
Avidity Biosciences
RNA
$5.99B
$70.6M 3.72% 1,727,388
TNGX icon
11
Tango Therapeutics
TNGX
$747M
$70.3M 3.7% 8,198,642
APLS icon
12
Apellis Pharmaceuticals
APLS
$3.48B
$66.2M 3.49% 1,726,000
ITOS icon
13
iTeos Therapeutics
ITOS
$43.7M 2.3% 2,946,915 +1,142,857 +63% +$17M
ARGX icon
14
argenx
ARGX
$43.6B
$43M 2.26% 100,000
AKRO icon
15
Akero Therapeutics
AKRO
$3.74B
$39.3M 2.07% 1,676,733
NKTX icon
16
Nkarta
NKTX
$151M
$33.1M 1.75% 5,607,350
ANAB icon
17
AnaptysBio
ANAB
$569M
$32.6M 1.72% 1,300,000
AXSM icon
18
Axsome Therapeutics
AXSM
$6.05B
$32.2M 1.7% 400,000
RCKT icon
19
Rocket Pharmaceuticals
RCKT
$354M
$31.6M 1.66% 1,466,051
FATE icon
20
Fate Therapeutics
FATE
$120M
$26.9M 1.42% 8,215,910
LEGN icon
21
Legend Biotech
LEGN
$6.41B
$26.6M 1.4% 600,000
THRD
22
DELISTED
Third Harmonic Bio
THRD
$26M 1.37% 2,000,000
GERN icon
23
Geron
GERN
$893M
$25.4M 1.34% 6,000,000
RCUS icon
24
Arcus Biosciences
RCUS
$1.13B
$24.4M 1.29% 1,602,200
XENE icon
25
Xenon Pharmaceuticals
XENE
$2.98B
$23.4M 1.23% 600,000